Punch & Associates Investment Management, Inc. Royalty Pharma PLC Transaction History
Punch & Associates Investment Management, Inc.
- $1.68 Billion
- Q3 2024
A detailed history of Punch & Associates Investment Management, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Punch & Associates Investment Management, Inc. holds 461,051 shares of RPRX stock, worth $14.2 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
461,051
Previous 424,541
8.6%
Holding current value
$14.2 Million
Previous $11.2 Million
16.51%
% of portfolio
0.78%
Previous 0.69%
Shares
3 transactions
Others Institutions Holding RPRX
# of Institutions
411Shares Held
283MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.26 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$1.16 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$708 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$496 Million0.35% of portfolio
-
Viking Global Investors LP12.1MShares$372 Million1.32% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $13.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...